ArticleJournal of gynecologic oncology2025

Bevacizumab in frontline chemotherapy improved the survival outcome for advanced ovarian clear cell carcinoma: a multicenter retrospective analysis.

Shinichi Tate et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.